Bildkälla: Stockfoto

Amniotics Q3 2022: Our Comments - Redeye

Redeye comments on the events of the third quarter, including progress with the main candidate PulmoStem and the selection of a new CEO. We also discuss the company's financials and financing.

Redeye comments on the events of the third quarter, including progress with the main candidate PulmoStem and the selection of a new CEO. We also discuss the company's financials and financing.
Börsvärldens nyhetsbrev
ANNONSER